Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Parkinsonism Relat Disord. 2014 Feb 22;20(5):525–529. doi: 10.1016/j.parkreldis.2014.02.012

Table 1.

Demographics of examined groups in the Brain and Body donation program. All neurodegenerative disease groups are not mutually exclusive. All data are listed as mean ± standard deviation.

PD DLB PSP MSA CBD Controls
Total 140 90 64 7 6 166
% Male 67.1% 56.7% 64.1% 42.9% 50.0% 56.0%
age of death 80±6.5 81±7.2 84±8.5* 74±7.4 75±5.7 83±9.3*
disease duration 15±2.5 7±4.1 8±6.2 5±1.7 7±1.9 n/a
Last UPDRS 42±20.3 35±26.8 33±19.5 43±28.2 n/a*** 8±6.8**
  months prior to death 12±11.5 19±14.4 33±19.5 17±12.1 n/a*** 16±16.2

PD had significant greater disease duration when compared to DLB, PSP, CBD, and MSA cases.

*

PSP and control cases were significantly older than PD, CBD, and MSA cases at death.

**

Controls had a significantly lower average UPDRS score before death when compared to PD, DLB, PSP, and MSA.

***

Only one CBD case had a record of a UPDRS.